Literature DB >> 3392206

Immunohistochemical localization of apolipoprotein E in human glial neoplasms.

M Murakami1, Y Ushio, Y Morino, T Ohta, Y Matsukado.   

Abstract

Immunocytochemical analyses revealed the presence and distribution of apolipoprotein E (apo E) in normal human brain tissue as well as in 77 human intracranial neoplasms. In normal brain tissues, the perikarya of astrocytes exhibited a strong positive reaction, whereas the Bergmann glia were stained to a moderate degree. However, no immunoreactivity was observed with neurons, oligodendrocytes, ependymal cells, and choroidal epithelium. Among the intracranial neoplasms, oligodendroglioma, choroid plexus papilloma, hemangioblastoma, primary malignant lymphoma, neurinoma, meningioma, pituitary adenoma, and craniopharyngioma were all negative. Immunoreactivity in the peripheral neuroblastoma was nil. However, the perikarya of astrocytomas and glioblastomas showed a positive reaction. Analyses on the degree of anaplasia and the amount of apo-E as an intensity of immunostaining showed a negative correlation. The astrocytic elements were stained in mixed oligoastrocytomas and medulloblastomas with glial differentiation. A few cases of ependymomas showed weak perikaryal immunostaining. Western blot analyses with anti-apo E antibody of a freshly prepared surgical specimen with astrocytomas revealed a single band with a molecular weight of approximately 37,000. The well differentiated cultured human astrocytoma cells secreted apo E into the medium. These lines of evidence suggest that apo E may serve as a potential marker specific for astrocytomas and glioblastomas, as well as an indicator of astrocytic tumor cell differentiation. The apo E localization in human brain tumors could be clinically relevant and diagnostically useful.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3392206      PMCID: PMC303492          DOI: 10.1172/JCI113568

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  The topographical distribution of S-100 and GFA proteins in the adult rat brain: an immunohistochemical study using horseradish peroxidase-labelled antibodies.

Authors:  S K Ludwin; J C Kosek; L F Eng
Journal:  J Comp Neurol       Date:  1976-01-15       Impact factor: 3.215

2.  Rate and equilibrium constants for binding of apo-E HDLc (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: evidence for multiple receptor binding of apo-E HDLc.

Authors:  R E Pitas; T L Innerarity; K S Arnold; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

3.  Apolipoproteins in human cerebrospinal fluid.

Authors:  P S Roheim; M Carey; T Forte; G L Vega
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence.

Authors:  A Bignami; L F Eng; D Dahl; C T Uyeda
Journal:  Brain Res       Date:  1972-08-25       Impact factor: 3.252

5.  High affinity binding of chylomicron remnants to rat liver plasma membranes.

Authors:  M Carrella; A D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

6.  The application of glial fibrillary acidic (GFA) protein immunohistochemistry in neurooncology. A progress report.

Authors:  S J de Armond; L F Eng; L J Rubinstein
Journal:  Pathol Res Pract       Date:  1980       Impact factor: 3.250

7.  The interaction of heparin with an apoprotein of human very low density lipoprotein.

Authors:  F A Shelburne; S H Quarfordt
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

8.  Immunohistochemical localization of glial fibrillary acidic protein in human glial neoplasms.

Authors:  M E Velasco; D Dahl; U Roessmann; P Gambetti
Journal:  Cancer       Date:  1980-02       Impact factor: 6.860

9.  Immunocytochemical demonstration of glial fibrillary acidic protein in mouse tanycytes.

Authors:  E Bascó; P L Woodhams; F Hajós; R Balázs
Journal:  Anat Embryol (Berl)       Date:  1981

10.  Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.

Authors:  D Y Hui; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1981-06-10       Impact factor: 5.157

View more
  15 in total

1.  Low-density lipoprotein receptors regulate microglial inflammation through c-Jun N-terminal kinase.

Authors:  Ana Pocivavsek; Mark P Burns; G William Rebeck
Journal:  Glia       Date:  2009-03       Impact factor: 7.452

Review 2.  The neurobiology of apolipoproteins in psychiatric disorders.

Authors:  J Gregor Sutcliffe; Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

3.  Polymeric nanomedicine for overcoming resistance mechanisms in hedgehog and Myc-amplified medulloblastoma.

Authors:  Virender Kumar; Qiyue Wang; Bharti Sethi; Feng Lin; Vinod Kumar; Donald W Coulter; Yuxiang Dong; Ram I Mahato
Journal:  Biomaterials       Date:  2021-09-29       Impact factor: 12.479

Review 4.  Meningiomas and Proteomics: Focus on New Potential Biomarkers and Molecular Pathways.

Authors:  Rosaria Viola Abbritti; Francesca Polito; Maria Cucinotta; Claudio Lo Giudice; Maria Caffo; Chiara Tomasello; Antonino Germanò; Mohammed Aguennouz
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

5.  Astrocytes derived from trisomic human embryonic stem cells express markers of astrocytic cancer cells and premalignant stem-like progenitors.

Authors:  Sailesh Gopalakrishna-Pillai; Linda E Iverson
Journal:  BMC Med Genomics       Date:  2010-04-27       Impact factor: 3.063

6.  Inhibition of c-Jun N-terminal kinase increases apoE expression in vitro and in vivo.

Authors:  Ana Pocivavsek; G William Rebeck
Journal:  Biochem Biophys Res Commun       Date:  2009-07-15       Impact factor: 3.575

7.  Expression of the protein chaperone, clusterin, in spinal cord cells constitutively and following cellular stress, and upregulation by treatment with Hsp90 inhibitor.

Authors:  Samantha Zinkie; Benoit J Gentil; Sandra Minotti; Heather D Durham
Journal:  Cell Stress Chaperones       Date:  2013-04-19       Impact factor: 3.667

8.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

Authors:  D E Schmechel; A M Saunders; W J Strittmatter; B J Crain; C M Hulette; S H Joo; M A Pericak-Vance; D Goldgaber; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

9.  Proteins with altered levels in plasma from glioblastoma patients as revealed by iTRAQ-based quantitative proteomic analysis.

Authors:  Poonam Gautam; Sudha C Nair; Manoj Kumar Gupta; Rakesh Sharma; Ravindra Varma Polisetty; Megha S Uppin; Challa Sundaram; Aneel K Puligopu; Praveen Ankathi; Aniruddh K Purohit; Giriraj R Chandak; H C Harsha; Ravi Sirdeshmukh
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

10.  Proteome analysis of human cerebrospinal fluid as a diagnostic biomarker in patients with meningioma.

Authors:  Jae Ho Kim; Sang Kwang Lee; Yong Cheol Yoo; Nam Hyun Park; Dan Bi Park; Jong Shin Yoo; Hyun Joo An; Young Mok Park; Kyung Gi Cho
Journal:  Med Sci Monit       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.